(Q36397226)

13 August 2017

1 reference

title

Can drug design inhibit abuse? (English)

1 reference

13 August 2017

John J Coleman

1

1 reference

13 August 2017

Peter B Bensinger

2

1 reference

13 August 2017

Mark S Gold

3

1 reference

13 August 2017

David E Smith

4

1 reference

13 August 2017

Robert P Bianchi

5

1 reference

13 August 2017

Robert L DuPont

6

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Journal of Psychoactive Drugs

13 August 2017

published in

1 reference

13 August 2017

volume

37

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

343-362

1 reference

Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Abuse potential of various opioid medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Pentazocine (Talwin) intoxication: report of 57 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

The incident reporting system does not detect adverse drug events: a problem for quality improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Cannabinoids and reward: interactions with the opioid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Identifying drug safety issues: from research to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Failed attempts at intranasal abuse of Concerta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Characteristics of methadone maintenance patients with chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Repeated improper intravenous injection of fentanyl from a transdermal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Fentanyl Use, Misuse, and Abuse: A Summary of 23 Postmortem Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Oral transmucosal abuse of transdermal fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Opioid therapy in patients with a history of substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Data quality of the Drug Abuse Warning Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Buprenorphine: a primer for emergency physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

A review of the reliability and validity of the Drug Abuse Warning Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

The Drug Abuse Warning Network (DAWN) Program. Toxicologic verification of 1,008 emergency room 'mentions'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Cocaine addiction: hypothesis derived from imaging studies with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2005.10399808

10.1080/02791072.2005.10399808

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference